Review article · 2021 · Open access

Current hurdles to the translation of nanomedicines from bench to the clinic

Snežana Đorđević, María Medel Gonzalez, Inmaculada Conejos‐Sánchez, Bárbara Carreira, Sabina Pozzi, Rita C. Acúrcio, Ronit Satchi‐Fainaro, Helena F. Florindo, Maria Jesus Vicent

Drug Delivery and Translational Research, 12(3), 500–525 · Published 23 July 2021 · DOI 10.1007/s13346-021-01024-2

Open PDFView at the publisherCite this paper

In brief

“Current hurdles to the translation of nanomedicines from bench to the clinic” is a 2021 review article by Snežana Đorđević and 8 co-authors, published in Drug Delivery and Translational Research. OpenAlex counts 833 citations as of 20 November 2026. It is open access under a CC BY licence: the full text is free to read at Drug Delivery and Translational Research.

Citations
833
Most cited in
2026 (379)
Field-weighted impact
3.33
References
188
Authors
9

Abstract

The field of nanomedicine has significantly influenced research areas such as drug delivery, diagnostics, theranostics, and regenerative medicine; however, the further development of this field will face significant challenges at the regulatory level if related guidance remains unclear and unconsolidated. This review describes those features and pathways crucial to the clinical translation of nanomedicine and highlights considerations for early-stage product development. These include identifying those critical quality attributes of the drug product essential for activity and safety, appropriate analytical methods (physical, chemical, biological) for characterization, important process parameters, and adequate pre-clinical models. Additional concerns include the evaluation of batch-to-batch consistency and considerations regarding scaling up that will ensure a successful reproducible manufacturing process. Furthermore, we advise close collaboration with regulatory agencies from the early stages of development to assure an aligned position to accelerate the development of future nanomedicines.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Đorđević, S., Gonzalez, M. M., Conejos‐Sánchez, I., Carreira, B., Pozzi, S., Acúrcio, R. C., Satchi‐Fainaro, R., Florindo, H. F., & Vicent, M. J. (2021). Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Delivery and Translational Research, 12(3), 500–525. https://doi.org/10.1007/s13346-021-01024-2

MLA 9

Đorđević, Snežana, et al. “Current hurdles to the translation of nanomedicines from bench to the clinic.” Drug Delivery and Translational Research, vol. 12, no. 3, 2021, pp. 500–525. https://doi.org/10.1007/s13346-021-01024-2.

Chicago

Đorđević, Snežana, María Medel Gonzalez, Inmaculada Conejos‐Sánchez, Bárbara Carreira, Sabina Pozzi, Rita C. Acúrcio, Ronit Satchi‐Fainaro, Helena F. Florindo, and Maria Jesus Vicent. 2021. “Current hurdles to the translation of nanomedicines from bench to the clinic.” Drug Delivery and Translational Research 12 (3): 500–525. https://doi.org/10.1007/s13346-021-01024-2.

Harvard

Đorđević, S. et al. (2021) ‘Current hurdles to the translation of nanomedicines from bench to the clinic’, Drug Delivery and Translational Research, 12(3), pp. 500–525. doi:10.1007/s13346-021-01024-2.

IEEE

S. Đorđević et al., “Current hurdles to the translation of nanomedicines from bench to the clinic,” Drug Delivery and Translational Research, vol. 12, no. 3, pp. 500–525, 2021, doi: 10.1007/s13346-021-01024-2.

BibTeX

@article{orevic2021current,
  title     = {{Current hurdles to the translation of nanomedicines from bench to the clinic}},
  author    = {Đorđević, Snežana and Gonzalez, María Medel and Conejos‐Sánchez, Inmaculada and Carreira, Bárbara and Pozzi, Sabina and Acúrcio, Rita C. and Satchi‐Fainaro, Ronit and Florindo, Helena F. and Vicent, Maria Jesus},
  journal   = {Drug Delivery and Translational Research},
  year      = {2021},
  volume    = {12},
  number    = {3},
  pages     = {500--525},
  doi       = {10.1007/s13346-021-01024-2},
  url       = {https://doi.org/10.1007/s13346-021-01024-2}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201811
202155
20223838
20236262
2024107107
2025240240
2026379379

Its field-weighted citation impact is 3.33: it has been cited 3.33 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • nanomedicine
  • clinical translation
  • regulatory guidelines
  • critical quality attributes
  • analytical methods
  • process parameters
  • preclinical models
  • batch-to-batch consistency

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Đorđević, S., Gonzalez, M. M., Conejos‐Sánchez, I., Carreira, B., Pozzi, S., Acúrcio, R. C., Satchi‐Fainaro, R., Florindo, H. F., & Vicent, M. J. (2021). Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Delivery and Translational Research, 12(3), 500–525. https://doi.org/10.1007/s13346-021-01024-2

How many times has this paper been cited?

833 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Drug Delivery and Translational Research: sign in and open the PDF from this page.

Who wrote this paper?

Snežana Đorđević, María Medel Gonzalez, Inmaculada Conejos‐Sánchez, Bárbara Carreira, Sabina Pozzi, Rita C. Acúrcio, Ronit Satchi‐Fainaro, Helena F. Florindo, Maria Jesus Vicent.

What is the DOI of this paper?

10.1007/s13346-021-01024-2, permanently at https://doi.org/10.1007/s13346-021-01024-2. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.